Rosia: A Single-Arm Study In More Than 1000 Patients (Pts) Receiving Front-Line Bevacizumab (Bev) Plus Chemotherapy (Ct) For Ovarian Cancer (Oc)
ANNALS OF ONCOLOGY（2012）
关键词
ovarian cancer,rosia,chemotherapy,single-arm,front-line
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要